HPV Vaccination and Cancer Prevention
Human papillomavirus, or HPV, is a common virus that spreads through se**al contact. Most people clear the infection on their own. However, certain high-risk strains can cause lasting changes in cells. These changes can later develop into cancer. Therefore, vaccination offers a strong way to prevent many HPV-related cancers before they start.
How HPV Leads to Cancer
HPV infects skin and mucous membranes. In most cases, the body fights off the virus within one or two years. Yet, persistent infection with high-risk types, especially HPV 16 and HPV 18, can trigger abnormal cell growth. Over time, these abnormal cells may turn into cancer. As a result, HPV is linked to nearly all cases of cervical cancer. It also causes many cancers of the vulva, vagina, penis, anus, and oropharynx.
Role of HPV Vaccines
HPV vaccines protect against the most dangerous strains. They train the immune system to recognise and block the virus before infection occurs. Consequently, the vaccines work best when given before any exposure to HPV. Health authorities recommend the vaccine for children around ages 9 to 14. Catch-up doses remain available for older teens and young adults in many countries. Moreover, some vaccines cover additional low-risk types that cause genital warts.
Impact on Cancer Prevention
Vaccination sharply reduces the risk of cervical cancer. Studies show large drops in precancerous lesions among vaccinated groups. In addition, rates of other HPV-related cancers have also begun to fall in places with strong vaccination programmes. The vaccine does not treat an existing infection. Therefore, regular screening, such as Pap tests or HPV tests, remains important even after vaccination. Together, vaccination and screening form a powerful two-step approach.
Safety and Coverage
HPV vaccines have a strong safety record. Common side effects include mild pain at the injection site or a short-lived fever. Serious reactions are rare. In addition, the vaccines do not contain live virus, so they cannot cause HPV infection. Many countries now include the HPV vaccine in their routine immunisation schedules. As a result, more young people gain protection before they become sexually active.
Looking Ahead
Wider use of HPV vaccination can prevent thousands of cancer cases each year. It also lowers the burden on healthcare systems. However, gaps in awareness and access still limit its full benefit in some regions. Therefore, continued education, school-based programmes, and affordable supply remain essential. With strong vaccination coverage and regular screening, most HPV-related cancers can be avoided.